Airsupra Could Help Revive AstraZeneca's Respiratory Fortunes
Will Soften Impact Of Declining Symbicort Sales
The US Food and Drug Administration has approved AstraZeneca and Avillion’s respiratory drug Airsupra, making it the only rescue medication cleared for as-needed use to reduce risk of asthma exacerbations.
